The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
Gluconeogenesis in Cancer: Function and Regulation of PEPCK, FBPase, and G6Pase
Abstract
Cancer cells display a high rate of glycolysis in the presence of oxygen to promote proliferation. Gluconeogenesis, the reverse pathway of glycolysis, can antagonize aerobic glycolysis in cancer via three key enzymes - phosphoenolpyruvate carboxykinase (PEPCK), fructose-1,6-bisphosphatase (FBPase), and glucose-6-phosphatase (G6Pase). Recent studies have revealed that, in addition to metabolic regulation, these enzymes also play a role in signaling, proliferation, and the cancer stem cell (CSC) tumor phenotype. Multifaceted regulation of PEPCK, FBPase, and G6Pase through transcription, epigenetics, post-translational modification, and enzymatic activity is observed in different cancers. We review here the function and regulation of key gluconeogenic enzymes and new therapeutic opportunities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
The emerging hallmarks of cancer metabolism
Pavlova, N. N., & Thompson, C. B. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.006 · Cited by 5,926
Regulation of cancer cell metabolism
Cairns, R. A., Harris, I. S., & Mak, T. W. (2011) · Nature Reviews Cancer · doi:10.1038/nrc2981 · Cited by 4,744
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06734 · Cited by 2,820
Association of reactive oxygen species levels and radioresistance in cancer stem cells
Diehn, M., Cho, R. W., Lobo, N. A., Kalisky, T., Dorie, M. J., Kulp, A. N., Qian, D., Lam, J. S., Ailles, L. E., Wong, M., et al. (2009) · Nature · doi:10.1038/nature07733 · Cited by 2,555
From Krebs to clinic: glutamine metabolism to cancer therapy
Altman, B. J., Stine, Z. E., & Dang, C. V. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.71 · Cited by 2,119
Regulation of cellular metabolism by protein lysine acetylation
Zhao, S., Xu, W., Jiang, W., Yu, W., Lin, Y., Zhang, T., Yao, J., Zhou, L., Zeng, Y., Li, H., et al. (2010) · Science · doi:10.1126/science.1179689 · Cited by 1,910
Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel?
Sabharwal, S. S., & Schumacker, P. T. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3803 · Cited by 1,622
Phosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses
Ho, P.-C., Bihuniak, J. D., Macintyre, A. N., Staron, M., Liu, X., Amezquita, R., Tsui, Y.-C., Cui, G., Micevic, G., Perales, J. C., et al. (2015) · Cell · doi:10.1016/j.cell.2015.08.012 · Cited by 1,462
Lactate Metabolism in Human Lung Tumors
Faubert, B., Li, K. Y., Cai, L., Hensley, C. T., Kim, J., Zacharias, L. G., Yang, C., Do, Q. N., Doucette, S., Burguete, D., et al. (2017) · Cell · doi:10.1016/j.cell.2017.09.019 · Cited by 1,343
Metabolic Instruction of Immunity
Buck, M. D., Sowell, R. T., Kaech, S. M., & Pearce, E. L. (2017) · Cell · doi:10.1016/j.cell.2017.04.004 · Cited by 1,214
Regulation of hepatic glucose metabolism in health and disease
Petersen, M. C., Vatner, D. F., & Shulman, G. I. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.80 · Cited by 1,133
Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy?
Hay, N. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.77 · Cited by 1,115
Loss of FBP1 by Snail-Mediated Repression Provides Metabolic Advantages in Basal-like Breast Cancer
Dong, C., Yuan, T., Wu, Y., Wang, Y., Fan, T. W. M., Miriyala, S., Lin, Y., Yao, J., Shi, J., Kang, T., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.01.022 · Cited by 804
Self-citationMetabolic Regulation of T Cell Longevity and Function in Tumor Immunotherapy
Kishton, R. J., Sukumar, M., & Restifo, N. P. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.06.016 · Cited by 548
Fructose-1,6-bisphosphatase opposes renal carcinoma progression
Li, B., Qiu, B., Lee, D. S. M., Walton, Z. E., Ochocki, J. D., Mathew, L. K., Mancuso, A., Gade, T. P. F., Keith, B., Nissim, I., et al. (2014) · Nature · doi:10.1038/nature13557 · Cited by 535
Partial and Transient Reduction of Glycolysis by PFKFB3 Blockade Reduces Pathological Angiogenesis
Schoors, S., De Bock, K., Cantelmo, A. R., Georgiadou, M., Ghesquière, B., Cauwenberghs, S., Kuchnio, A., Wong, B. W., Quaegebeur, A., Goveia, J., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2013.11.008 · Cited by 529
Jiang, W., Wang, S., Xiao, M., Lin, Y., Zhou, L., Lei, Q., Xiong, Y., Guan, K.-L., & Zhao, S. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.04.028 · Cited by 415
Cong, J., Wang, X., Zheng, X., Wang, D., Fu, B., Sun, R., Tian, Z., & Wei, H. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.06.021 · Cited by 380
Pyruvate carboxylation enables growth of SDH-deficient cells by supporting aspartate biosynthesis
Cardaci, S., Zheng, L., MacKay, G., van den Broek, N. J. F., MacKenzie, E. D., Nixon, C., Stevenson, D., Tumanov, S., Bulusu, V., Kamphorst, J. J., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3233 · Cited by 286
What Is the Metabolic Role of Phosphoenolpyruvate Carboxykinase?
Yang, J., Kalhan, S. C., & Hanson, R. W. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.r109.040543 · Cited by 284
Vincent, E. E., Sergushichev, A., Griss, T., Gingras, M.-C., Samborska, B., Ntimbane, T., Coelho, P. P., Blagih, J., Raissi, T. C., Choinière, L., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.08.013 · Cited by 279
Voehringer, D. W., Hirschberg, D. L., Xiao, J., Lu, Q., Roederer, M., Lock, C. B., Herzenberg, L. A., Steinman, L., & Herzenberg, L. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.6.2680 · Cited by 260
PEPCK Coordinates the Regulation of Central Carbon Metabolism to Promote Cancer Cell Growth
Montal, E. D., Dewi, R., Bhalla, K., Ou, L., Hwang, B. J., Ropell, A. E., Gordon, C., Liu, W.-J., DeBerardinis, R. J., Sudderth, J., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.09.025 · Cited by 259
Wang, B., Hsu, S.-H., Frankel, W., Ghoshal, K., & Jacob, S. T. (2012) · Hepatology · doi:10.1002/hep.25632 · Cited by 241
Elgogary, A., Xu, Q., Poore, B., Alt, J., Zimmermann, S. C., Zhao, L., Fu, J., Chen, B., Xia, S., Liu, Y., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1611406113 · Cited by 234
Glycogen storage disease type I and G6Pase-β deficiency: etiology and therapy
Chou, J. Y., Jun, H. S., & Mansfield, B. C. (2010) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.189 · Cited by 234
Lussey-Lepoutre, C., Hollinshead, K. E. R., Ludwig, C., Menara, M., Morin, A., Castro-Vega, L.-J., Parker, S. J., Janin, M., Martinelli, C., Ottolenghi, C., et al. (2015) · Nature Communications · doi:10.1038/ncomms9784 · Cited by 227
Zhang, P., Tu, B., Wang, H., Cao, Z., Tang, M., Zhang, C., Gu, B., Li, Z., Wang, L., Yang, Y., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1411026111 · Cited by 224
Liu, M.-X., Jin, L., Sun, S.-J., Liu, P., Feng, X., Cheng, Z.-L., Liu, W.-R., Guan, K.-L., Shi, Y.-H., Yuan, H.-X., et al. (2018) · Oncogene · doi:10.1038/s41388-017-0070-6 · Cited by 212
Ros, S., Santos, C. R., Moco, S., Baenke, F., Kelly, G., Howell, M., Zamboni, N., & Schulze, A. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0234 · Cited by 201
PCK2 activation mediates an adaptive response to glucose depletion in lung cancer
Leithner, K., Hrzenjak, A., Trötzmüller, M., Moustafa, T., Köfeler, H. C., Wohlkoenig, C., Stacher, E., Lindenmann, J., Harris, A. L., Olschewski, A., et al. (2015) · Oncogene · doi:10.1038/onc.2014.47 · Cited by 200
Méndez-Lucas, A., Hyroššová, P., Novellasdemunt, L., Viñals, F., & Perales, J. C. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.566927 · Cited by 199
Warburg effect revisited: an epigenetic link between glycolysis and gastric carcinogenesis
Liu, X., Wang, X., Zhang, J., Lam, E. K. Y., Shin, V. Y., Cheng, A. S. L., Yu, J., Chan, F. K. L., Sung, J. J. Y., & Jin, H. C. (2010) · Oncogene · doi:10.1038/onc.2009.332 · Cited by 194
Gain of Glucose-Independent Growth upon Metastasis of Breast Cancer Cells to the Brain
Chen, J., Lee, H.-J., Wu, X., Huo, L., Kim, S.-J., Xu, L., Wang, Y., He, J., Bollu, L. R., Gao, G., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2268 · Cited by 187
Wnt Signaling Regulates Hepatic Metabolism
Liu, H., Fergusson, M. M., Wu, J. J., Rovira, I. I., Liu, J., Gavrilova, O., Lu, T., Bao, J., Han, D., Sack, M. N., et al. (2011) · Science Signaling · doi:10.1126/scisignal.2001249 · Cited by 174
Guidelines for the selection of functional assays to evaluate the hallmarks of cancer
Menyhárt, O., Papp, H., Sukumar, S. V., Schäfer, R., Magnani, L., de Barrios, O., & Győrffy, B. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.10.002 · Cited by 167
Switch of glycolysis to gluconeogenesis by dexamethasone for treatment of hepatocarcinoma
Ma, R., Zhang, W., Tang, K., Zhang, H., Zhang, Y., Li, D., Li, Y., Xu, P., Luo, S., Cai, W., et al. (2013) · Nature Communications · doi:10.1038/ncomms3508 · Cited by 163
Hirata, H., Sugimachi, K., Komatsu, H., Ueda, M., Masuda, T., Uchi, R., Sakimura, S., Nambara, S., Saito, T., Shinden, Y., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2601 · Cited by 163
Wong, C., Wei, L., Law, C., Ho, D. W., Tsang, F. H., Au, S. L., Sze, K. M., Lee, J. M., Wong, C. C., & Ng, I. O. (2016) · Hepatology · doi:10.1002/hep.28304 · Cited by 162
Reassessing triglyceride synthesis in adipose tissue
Nye, C., Kim, J., Kalhan, S. C., & Hanson, R. W. (2008) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2008.08.003 · Cited by 159
Pyruvate and metabolic flexibility: illuminating a path toward selective cancer therapies
Olson, K. A., Schell, J. C., & Rutter, J. (2016) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2016.01.002 · Cited by 154
Belkaid, A., Currie, J.-C., Desgagnés, J., & Annabi, B. (2006) · Cancer Cell International · doi:10.1186/1475-2867-6-7 · Cited by 153
Chen, M., Zhang, J., Li, N., Qian, Z., Zhu, M., Li, Q., Zheng, J., Wang, X., & Shi, G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025564 · Cited by 150
Stark, R., Pasquel, F., Turcu, A., Pongratz, R. L., Roden, M., Cline, G., Shulman, G., & Kibbey, R. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.011775 · Cited by 146
Identification of a multienzyme complex for glucose metabolism in living cells
Kohnhorst, C. L., Kyoung, M., Jeon, M., Schmitt, D. L., Kennedy, E. L., Ramirez, J., Bracey, S. M., Luu, B. T., Russell, S. J., & An, S. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.783050 · Cited by 139
Bian, X., Chen, H., Yang, P., Li, Y.-P., Zhang, F.-N., Zhang, J.-Y., Wang, W.-J., Zhao, W., Zhang, S., Chen, Q.-T., et al. (2017) · Nature Communications · doi:10.1038/ncomms14420 · Cited by 137
Jin, X., Pan, Y., Wang, L., Zhang, L., Ravichandran, R., Potts, P. R., Jiang, J., Wu, H., & Huang, H. (2017) · Oncogenesis · doi:10.1038/oncsis.2017.21 · Cited by 131
Bárcena‐Varela, M., Caruso, S., Llerena, S., Álvarez‐Sola, G., Uriarte, I., Latasa, M. U., Urtasun, R., Rebouissou, S., Alvarez, L., Jimenez, M., et al. (2019) · Hepatology · doi:10.1002/hep.30168 · Cited by 130
Exploring Metabolic Configurations of Single Cells within Complex Tissue Microenvironments
Miller, A., Nagy, C., Knapp, B., Laengle, J., Ponweiser, E., Gröger, M., Starkl, P. M., Bergmann, M. M., Wagner, O. F., & Haschemi, A. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.08.014 · Cited by 123
Liang, J., Liu, C., Qiao, A., Cui, Y., Zhang, H., Cui, A., Zhang, S., Yang, Y., Xiao, X., Chen, Y., et al. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.10.024 · Cited by 119
Cancer heterogeneity is not compatible with one unique cancer cell metabolic map
Strickaert, A., Saiselet, M., Dom, G., Deken, X. D., Dumont, J. E., Féron, O., Sonveaux, P., & Maenhaut, C. (2016) · Oncogene · doi:10.1038/onc.2016.411 · Cited by 112
Lee, P., Vousden, K. H., & Cheung, E. C. (2014) · Cancer & Metabolism · doi:10.1186/2049-3002-2-1 · Cited by 106
Yang, H. J., Jin, X., Yan, Y., Shao, Y., Pan, Y., Roberts, L. R., Zhang, J., Huang, H., & Jiang, J. (2017) · Scientific Reports · doi:10.1038/srep43864 · Cited by 103
Kondaveeti, Y., Reed, I. K. G., & White, B. A. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.04.025 · Cited by 101
Nelson, M. E., Lahiri, S., Chow, J. D. Y., Byrne, F. L., Hargett, S. R., Breen, D. S., Olzomer, E. M., Wu, L. E., Cooney, G. J., Turner, N. A., et al. (2017) · Nature Communications · doi:10.1038/ncomms14689 · Cited by 98
Jin, X., Pan, Y., Wang, L., Ma, T., Zhang, L., Tang, A., Billadeau, D. D., Wu, H., & Huang, H. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-3143 · Cited by 98
Li, H., Wang, J., Xu, H., Xing, R., Pan, Y., Li, W., Cui, J., Zhang, H., & Lu, Y. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-110 · Cited by 89
Koide, S., Oshima, M., Takubo, K., Yamazaki, S., Nitta, E., Saraya, A., Aoyama, K., Kato, Y., Miyagi, S., Nakajima‐Takagi, Y., et al. (2016) · Blood · doi:10.1182/blood-2016-01-694810 · Cited by 89
Li, Y., Luo, S., Ma, R., Liu, J., Xu, P., Zhang, H., Tang, K., Ma, J., Zhang, Y., Liang, X., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2615 · Cited by 88
Gao, Y., Wang, X., Sang, Z., Li, Z., Liu, F., Mao, J., Yan, D., Zhao, Y., Wang, H., Li, P., et al. (2017) · Scientific Reports · doi:10.1038/srep45913 · Cited by 86
Hall, R. K., Wang, X. L., George, L., Koch, S. R., & Granner, D. K. (2006) · Molecular Endocrinology · doi:10.1210/me.2006-0307 · Cited by 85
Glucose-6–phosphatase Is a Key Metabolic Regulator of Glioblastoma Invasion
Abbadi, S., Rodarte, J. J., Abutaleb, A., Lavell, E., Smith, C. L., Ruff, W. E., Schiller, J. L., Olivi, A., Levchenko, A., Guerrero‐Cazares, H., et al. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0106-t · Cited by 85
Roles of pyruvate carboxylase in human diseases: from diabetes to cancers and infection
Lao-On, U., Attwood, P. V., & Jitrapakdee, S. (2018) · Journal of Molecular Medicine · doi:10.1007/s00109-018-1622-0 · Cited by 85
Nuclear Mechanisms of Insulin Resistance
Kang, S., Tsai, L. T.-Y., & Rosen, E. D. (2016) · Trends in Cell Biology · doi:10.1016/j.tcb.2016.01.002 · Cited by 84
6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells
Ros, S., Flöter, J., Kaymak, I., Da Costa, C., Houddane, A., Dubuis, S., Griffiths, B., Mitter, R., Walz, S., Blake, S., et al. (2017) · Oncogene · doi:10.1038/onc.2016.477 · Cited by 83
Moore, L. E., Jaeger, E., Nickerson, M. L., Brennan, P., Vries, S. D., Roy, R., Toro, J. R., Li, H., Karami, S., Lenz, P., et al. (2012) · Oncogenesis · doi:10.1038/oncsis.2012.14 · Cited by 82
Glioma Cells with the IDH1 Mutation Modulate Metabolic Fractional Flux through Pyruvate Carboxylase
Izquierdo-García, J. L., Cai, L. M., Chaumeil, M. M., Eriksson, P., Robinson, A. E., Pieper, R. O., Phillips, J. J., & Ronen, S. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108289 · Cited by 78
Jiang, L., Xiong, J., Zhan, J., Yuan, F., Tang, M., Zhang, C., Cao, Z., Chen, Y., Lu, X., Li, Y., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.780130 · Cited by 77
Downregulation of PCK2 remodels tricarboxylic acid cycle in tumor-repopulating cells of melanoma
Luo, S., Li, Y., Ma, R., Liu, J., Xu, P., Zhang, H.-B., Tang, K., Ma, J., Liu, N., Zhang, Y., et al. (2017) · Oncogene · doi:10.1038/onc.2016.520 · Cited by 74
Latorre‐Muro, P., Baeza, J., Armstrong, E. A., Hurtado‐Guerrero, R., Corzana, F., Wu, L. E., Sinclair, D. A., López‐Buesa, P., Carrodeguas, J. A., & Denu, J. M. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.07.031 · Cited by 74
Zhu, Y., Shi, M., Chen, H., Gu, J., Zhang, J., Shen, B., Deng, X., Xie, J., Zhan, X., & Peng, C. (2015) · Oncotarget · doi:10.18632/oncotarget.4167 · Cited by 73
mTORC2 controls cancer cell survival by modulating gluconeogenesis
Khan, M. W., Biswas, D., Ghosh, M., Mandloi, S., Chakrabarti, S., & Chakrabarti, P. (2015) · Cell Death Discovery · doi:10.1038/cddiscovery.2015.16 · Cited by 73
Leithner, K., Triebl, A., Trötzmüller, M., Hinteregger, B., Leko, P., Wieser, B. I., Grasmann, G., Bertsch, A., Züllig, T., Stacher, E., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1719871115 · Cited by 70
Molecular mechanisms of [18F]fluorodeoxyglucose accumulation in liver cancer
Izuishi, K., Yamamoto, Y., Mori, H., Kameyama, R., Fujihara, S., Masaki, T., & Suzuki, Y. (2013) · Oncology Reports · doi:10.3892/or.2013.2886 · Cited by 68
Zhang, J., Wang, J., Xing, H., Li, Q., Zhao, Q., & Li, J. (2015) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-015-2595-8 · Cited by 67
Glycolytic reprogramming through PCK2 regulates tumor initiation of prostate cancer cells
Zhao, J., Li, J., Fan, T. W. ‐., & Hou, X. S. (2017) · Oncotarget · doi:10.18632/oncotarget.18787 · Cited by 63
Lord‐Dufour, S., Copland, I. B., Levros, L.-C., Post, M., Das, A., Khosla, C., Galipeau, J., Rassart, É., & Annabi, B. (2008) · Stem Cells · doi:10.1634/stemcells.2008-0855 · Cited by 60
Suppression of Gluconeogenic Gene Expression by LSD1-Mediated Histone Demethylation
Pan, D., Mao, C., & Wang, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066294 · Cited by 58
Shi, H., Fang, R., Li, Y., Li, L., Zhang, W., Wang, H., Chen, F., Zhang, S., Zhang, X., & Ye, L. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.08.025 · Cited by 52
Hanson, R. W. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.r109.040519 · Cited by 47
Sanders, E. B., & Diehl, S. (2015) · Oncoscience · doi:10.18632/oncoscience.128 · Cited by 46
Cancer Cells Hijack Gluconeogenic Enzymes to Fuel Cell Growth
Balsa-Martinez, E., & Puigserver, P. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.11.005 · Cited by 44
Wei, L., Zhou, Y., Yao, J., Qiao, C., Ni, T., Guo, R., Guo, Q., & Lu, N. (2015) · Oncotarget · doi:10.18632/oncotarget.3838 · Cited by 43
Neuronal Progenitor Maintenance Requires Lactate Metabolism and PEPCK-M-Directed Cataplerosis
Álvarez, Z., Hyroššová, P., Perales, J. C., & Alcántara, S. (2014) · Cerebral Cortex · doi:10.1093/cercor/bhu281 · Cited by 43
Guo, T., Chen, T., Gu, C., Li, B., & Xu, C. (2015) · Tumor Biology · doi:10.1007/s13277-015-3463-6 · Cited by 41
Cancer anabolic metabolism inhibitors move into clinic
Garber, K. (2016) · Nature Biotechnology · doi:10.1038/nbt0816-794 · Cited by 41
Fructose-1,6-Bisphosphatase 1 Reduces18F FDG Uptake in Hepatocellular Carcinoma
Chen, R., Li, J., Zhou, X., Liu, J., & Huang, G. (2017) · Radiology · doi:10.1148/radiol.2017161607 · Cited by 41
Metabolic plasticity in heterogeneous pancreatic ductal adenocarcinoma
Liang, C., Qin, Y., Zhang, B., Ji, S., Shi, S., Xu, W., Liu, J., Xiang, J., Liang, D., Hu, Q., et al. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.09.001 · Cited by 40
Gautier‐Stein, A., Soty, M., Chilloux, J., Zitoun, C., Rajas, F., & Mithieux, G. (2012) · Diabetes · doi:10.2337/db11-0986 · Cited by 39
Fructose-1,6-bisphosphatase is a novel regulator of Wnt/β-Catenin pathway in breast cancer
Li, K., Ying, M., Feng, D., Du, J., Chen, S., Dan, B., Wang, C., & Wang, Y. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.10.050 · Cited by 37
Targeted knockdown of polo-like kinase 1 alters metabolic regulation in melanoma
Gutteridge, R. E. A., Singh, C. K., Ndiaye, M. A., & Ahmad, N. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.02.013 · Cited by 34
Park, S.-K., Haase, V. H., & Johnson, R. S. (2007) · International Journal of Oncology · doi:10.3892/ijo.30.2.341 · Cited by 32
Aberrant methylation of human L- and M-fructose 1,6-bisphosphatase genes in cancer
Bigl, M., Jandrig, B., Horn, L., & Eschrich, K. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.10.045 · Cited by 30
Park, J., Kim, S. C., Kim, W. K., Hong, J. P., Kim, K., Yeo, H. Y., Lee, J. Y., Kim, M. S., Kim, J. H., Yang, S. Y., et al. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-160 · Cited by 28
Fortier, S., Labelle, D., Sina, A., Moreau, R., & Annabi, B. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.01.061 · Cited by 28
Shang, F., Liu, M., Li, B., Zhang, X., Sheng, Y., Liu, S., Han, J., Li, H., & Xiu, R. (2016) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-016-3030-x · Cited by 28
Kim, G., Kwon, J. H., Cho, J., Zhang, L., Mansfield, B. C., & CHOU, J. Y. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx097 · Cited by 25
Cell cycle-dependent expression and subcellular localization of fructose 1,6-bisphosphatase
Mamczur, P., Sok, A. J., Rzechonek, A., & Rakus, D. (2011) · Histochemistry and Cell Biology · doi:10.1007/s00418-011-0884-1 · Cited by 24
Seenappa, V., Das, B., Joshi, M. B., & Satyamoorthy, K. (2016) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25543 · Cited by 19
Cited by
Mechanisms of Metabolic Reprogramming in Cancer Cells Supporting Enhanced Growth and Proliferation
Schiliro, C., & Firestein, B. L. (2021) · Cells · doi:10.3390/cells10051056 · Cited by 615
FOXO transcription factor family in cancer and metastasis
Jiramongkol, Y., & Lam, E. W.-F. (2020) · Cancer and Metastasis Reviews · doi:10.1007/s10555-020-09883-w · Cited by 281
The role of lipid metabolic reprogramming in tumor microenvironment
Yang, K., Wang, X., Song, C., He, Z., Wang, R., Xu, Y., Jiang, G., Wan, Y., Mei, J., & Mao, W. (2023) · Theranostics · doi:10.7150/thno.82920 · Cited by 270
Metabolic reprogramming in triple-negative breast cancer
Wang, Z., Jiang, Q., & Dong, C. (2020) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2019.0210 · Cited by 248
“Ubiquitous loss of FBP1 in TNBC is required for the maintenance of aerobic glycolysis and the CSC phenotype 91,93 .”
Background
Metadata
- Authors
- Wang, Z., & Dong, C.
- Venue
- Trends in Cancer
- Publisher
- Elsevier BV
- Published
- 2019-01
- Volume
- 5
- Issue
- 1
- Pages
- 30-45
- ISSN
- 2405-8025 (ISSN-L)
- 2405-8033
- OpenAlex
- W2905965925
- Cited by
- 293
- References
- 100
- FWCI
- 2.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.